Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.

导出 OA

翻译打印收藏纠错

第一作者： Gerald,Voss

第一单位： Coalition for Epidemic Preparedness and Innovation, London, UK. Electronic address: Gerald.voss@cepi.net.

作者： Gerald,Voss ^[1] ; Jeanne-Marie,Jacquet ^[2] ; Nadia,Tornieporth ^[3] ; Beate,Kampmann ^[4] ; Ruth,Karron ^[5] ; Ajoke Sobanjo-Ter,Meulen ^[6] ; Robert,Chen ^[7] ; Marion,Gruber ^[8] ; Nicole,Lurie ^[2] ; Charlie,Weller ^[9] ; Jakob P,Cramer ^[2] ; Melanie,Saville ^[2] ; Mimi,Darko ^[10]

作者单位： Coalition for Epidemic Preparedness and Innovation, London, UK. Electronic address: Gerald.voss@cepi.net. ^[1] Coalition for Epidemic Preparedness and Innovation, London, UK. ^[2] University of Applied Sciences and Arts, Hanover, Germany. ^[3] The Vaccine Centre, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK. ^[4] Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. ^[5] Bill & Melinda Gates Foundation, Seattle, WA, USA. ^[6] Brighton Collaboration, Task Force for Global Health, Decatur, GA, USA. ^[7] Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. ^[8] Vaccines Programme, Wellcome Trust, London, UK. ^[9] Food and Drugs Authority, Cantonments, Accra, Ghana. ^[10]

关键词 Emerging infectious diseases Lassa virus fever Maternal immunization Pregnancy Vaccines